SCTIMST – BMT Wing is actively engaged in applied and translational research in areas of biomedical devices, biologics and biomaterials since late 1970s. The technologies developed indigenously by SCTIMST have been transferred to several industries, which have benefitted both the industry and society at large. Our record is marked with development of innovative and popular products such as the artificial heart valve ( TTK Healthcare Ltd), blood bags (Peninsula polymers, now Terumo Penpol Ltd, HLL Lifecare Ltd), hydrocephalus shunt (HLL Lifecare Ltd), membrane oxygenator & cardiotomy reservoirs (SIDD Lifesciences Ltd), bioceramic composites for dental and orthopedic applications (Basic Healthcare Ltd), dental composites (Anabond Stedmann Pharma Ltd), Intrauterine Device (HLL Lifecare Ltd) to name a few.
SCTIMST is now offering technologies for licensing to enterprises including start ups for further scaling up and commercialization. These technologies are available in different stages of readiness levels such as proof of concept, pre-clinical / clinical evaluation. The technologies can be licensed to industries either on exclusive or non-exclusive basis against payment of a combination of up-front licence fee and annual royalties, which will vary from project to project. More information on Expression of Interest (EoI) is available from the below links.
Interested parties may submit EoI in proforma as specified indicating the technology/product of interest in sealed cover addressed to Head, BMT Wing, SCTIMST, Poojapura, Thiruvananthapuram – 695012, latest by 31st July 2018
Pre-bid discussions shall be entertained from 5th June 2018 to 15th July 2018. For further details, visits to Institute and pre-bid discussions, please contact Technology Business Division on phone -0471-2520309/308 or email: email@example.com.